CD14 and COVID-19: For instance, a recent case report showed that interferon-γ treatment led to a significant improvement in CD14+ monocyte HLA-DR levels, providing an improvement in the clinical status of a patient with severe COVID-19 and a diagnosis of severe sepsis with multiple multiresistant bacterial confections [32].